Scroll Down to see more

Acrux is a pharmaceutical company dedicated to developing and commercialising specialty and generic topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised, through licensees, a number of pharmaceutical products in the US, Europe and other markets. Marketed products include Axiron®, Evamist® and Lenzetto®.